Angiotensin II contributes to renal fibrosis independently of notch pathway activation

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Lavoz, Carolina ^a   Rodrigues Diez, Raquel ^a   Benito Martin, Alberto ^b   Rayego Mateos, Sandra ^a   Rodrigues Diez, Raúl R ^a   Alique, Matilde ^a   Ortiz, Alberto ^b   Mezzano, Sergio ^c   Egido, Jesús ^b   Ruiz Ortega, Marta ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^c UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; JAGGED1; LOSARTAN; NOTCH RECEPTOR; NOTCH1 RECEPTOR; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL TRANSPORT; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; HORMONE ACTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY TUBULE CELL; MALE; MOUSE; NONHUMAN; NOTCH SIGNALING PATHWAY; PODOCYTE; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RAT; RECEPTOR BLOCKING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TISSUE REGENERATION; UPREGULATION; URETER OBSTRUCTION;

ANGIOTENSIN II; ANIMALS; CALCIUM-BINDING PROTEINS; CELL LINE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLASTS; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; HYDRONEPHROSIS; HYPERTENSION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; KIDNEY TUBULES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; PODOCYTES; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

MUS; RATTUS;

EID: 84863624021     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040490     Document Type: Article

References (55)

1. McCright B, Gao X, Shen L, Lozier J, Lan Y, et al. (2001) Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development 128(4): 491-502.
2. McLaughlin KA, Rones MS, Mercola M, (2000) Notch regulates cell fate in the developing pronephros. Dev Biol 227(2): 567-580.
3. Piscione TD, Wu MY, Quaggin SE, (2004) Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. Gene Expr Patterns 4(6): 707-711.
4. Artavanis-Tsakonas S, Rand MD, Lake RJ, (1999) Notch signaling: cell fate control and signal integration in development. Science 284(5415): 770-776.
5. Zavadil J, Cermak L, Soto-Nieves N, Böttinger EP, (2004) Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 23: 1155-1165.
6. Bray SJ, (2006) Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7(9): 678-689.
7. Shimizu K, Chiba S, Saito T, Kumano K, Hirai H, (2000) Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. Biochem Biophys Res Commun 276: 385-389.
8. Lindsell CE, Shawber CJ, Boulter J, Weinmaster G, (1995) Jagged: a mammalian ligand that activates Notch1. Cell 80: 909-917.
9. Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, et al. (1995) Signalling downstream of activated mammalian Notch. Nature 377: 355-358.
10. Fortini ME, (2009) Notch signalling: The core pathway and its posttranslational regulation. Dev Cell 16: 633-647.
11. Ranganathan P, Weaver KL, Capobianco AJ, (2011) Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 11(5): 338-51.
12. Lindner V, Booth C, Prudovsky I, Small D, Maciag T, et al. (2001) Members of the Jagged/Notch gene families are expressed in injured arteries and regulate cell phenotype via alterations in cell matrix and cell-cell interaction. Am J Pathol 159(3): 875-883.
13. Kwon SM, Alev C, Asahara T, (2009) The role of notch signaling in endothelial progenitor cell biology. Trends Cardiovasc Med 19(5): 170-3.
14. Lasagni L, Ballerini L, Angelotti ML, Parente E, Sagrinati C, et al. (2010) Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells 28(9): 1674-85.
15. Murea M, Park JK, Sharma S, Kato H, Gruenwald A, et al. (2010) Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int 78(5): 514-22.
16. Niranjan T, Bielesz B, Gruenwald A, Ponda MP, Kopp JB, et al. (2008) The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 14(3): 290-8.
17. Waters AM, Wu MY, Onay T, Scutaru J, Liu J, et al. (2008) Ectopic notch activation in developing podocytes causes glomerulosclerosis. J Am Soc Nephrol. 19(6): 1139-57.
18. Morrissey J, Guo G, Moridaira K, Fitzgerald M, McCracken R, et al. (2002) Transforming growth factor-beta induces renal epithelial jagged-1 expression in fibrotic disease. J Am Soc Nephrol 13(6): 1499-1508.
19. Niimi H, Pardali K, Vanlandewijck M, Heldin CH, Moustakas A, (2007) Notch signaling is necessary for epithelial growth arrest by TGF-beta. J Cell Biol 26 176(5): 695-707.
20. Bielesz B, Sirin Y, Si H, Niranjan T, Gruenwald A, et al. (2010) Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 120(11): 4040-54.
21. Gupta S, Li S, Abedin MJ, Wang L, Schneider E, et al. (2010) Source Effect of Notch activation on the regenerative response to acute renal failure. Am J Physiol Renal Physiol 298(1): F209-15.
22. Zeisberg M, Neilson EG, (2010) Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21(11): 1819-34.
23. Leask A, Abraham DJ, (2004) TGF-beta signaling and the fibrotic response. FASEB J 18: 816-827.
24. Liu Y, (2010) New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 21: 212-22.
25. Zavadil J, Bottinger EP, (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24(37): 5764-5774.
26. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, (1999) Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 56(4): 1455-1467.
27. Nyhan KC, Faherty N, Murray G, Cooey LB, Godson C, et al. (2010) Jagged/Notch signalling is required for a subset of TGF-β1 responses in human kidney epithelial cells. Biochim Biophys Acta 1803(12): 1386-95.
28. Ruiz-Ortega M, Ruperez M, Esteban V, Rodriguez-Vita J, Sanchez-Lopez E, et al. (2006) Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 21(1): 16-20.
29. Wolf G, (2006) Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int 70: 1914-1919.
30. Ruiz-Ortega M, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J, (2007) TGF-beta signaling in vascular fibrosis. Cardiovasc Res 74(2): 196-206.
31. Daniel C, (2008) Blocking of angiotensin II is more than blocking of transforming growth factor-beta. Kidney Int 74(5): 551-3.
32. Carvajal G, Rodríguez-Vita J, Rodrigues-Díez R, Sánchez-López E, Rupérez M, et al. (2008) Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. Kidney Int 74(5): 585-95.
33. McCright B, (2003) Notch signaling in kidney development. Curr Opin Nephrol Hypertens 12(1): 5-10.
34. Rodrigues-Díez R, Carvajal-González G, Sánchez-López E, Rodríguez-Vita J, Rodrigues Díez R, et al. (2008) Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways. Pharm Res 25(10): 2447-61.
35. Chen L, Liu BC, Zhang XL, Zhang JD, Liu H, et al. (2006) Influence of connective tissue growth factor antisense oligonucleotide on angiotensin II-induced epithelial mesenchymal transition in HK2 cells. Acta Pharmacol Sin 27(8): 1029-36.
36. Rupérez M, Lorenzo O, Blanco-Colio LM, Esteban V, Egido J, et al. (2003) Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circulation 108: 1499-1505.
37. Walsh DW, Roxburgh SA, McGettigan P, Berthier CC, Higgins DG, et al. (2008) Co-regulation of Gremlin and Notch signalling in diabetic nephropathy. Biochim Biophys Acta 1782(1): 10-21.
38. Esteban V, Lorenzo O, Rupérez M, Suzuki Y, Mezzano S, et al. (2004) Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol 15(6): 1514-29.
39. Klahr S, Morrissey J, (2002) Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol. 283(5): F861-75.
40. Moustakas A, Heldin CH, (2007) Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98: 1512-1520.
41. Grego-Bessa J, Diez J, Timmerman L, de la Pompa JL, (2004) Notch and epithelial-mesenchyme transition in development and tumor progression: another turn of the screw. Cell Cycle 3(6): 718-721.
42. Zeisberg M, Kalluri R, (2008) Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis. Front Biosci 13: 6991-8.
43. Zeisberg M, Duffield JS, (2010) Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 21: 1247-1253.
44. Kriz W, Kaissling B, Le Hir M, (2011) Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 121(2): 468-74.
45. Weisberg AD, Albornoz F, Griffin JP, Crandall DL, Elokdah H, et al. (2005) Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling. Arterioscler Thromb Vasc Biol 25(2): 365-71.
46. Rodrigues Díez R, Rodrigues-Díez R, Lavoz C, Rayego-Mateos S, Civantos E, et al. (2010) Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process. PLoS One 30 5(11): e14145.
47. Kretzler M, Allred L, (2008) Notch inhibition reverses kidney failure. Nat Med 14(3): 246-7.
48. Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P, et al. (2001) Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 108: 807-816.
49. Lin CL, Wang FS, Hsu YC, Chen CN, Tseng MJ, et al. (2010) Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy. Diabetes 59(8): 1915-25.
50. Sanchez-Niño MD, Sanz AB, Sanchez-Lopez E, Ruiz-Ortega M, Benito-Martin A, et al. (2012) HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II. Lab Invest 92(1): 32-45.
51. Campos AH, Wang W, Pollman MJ, Gibbons GH, (2002) Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells: implications in cell-cycle regulation. Circ Res 29 91(11): 999-1006.
52. Boulos N, Helle F, Dussaule JC, Placier S, Milliez P, et al. (2011) Notch3 is essential for regulation of the renal vascular tone. Hypertension 57(6): 1176-82.
53. Challen GA, Bertoncello I, Deane JA, Ricardo SD, Little MH, (2006) Kidney side population reveals multilineage potential and renal functional capacity but also cellular heterogeneity. J Am Soc Nephrol 17(7): 1896-912.
54. Saleem MA, O'Hare MJ, Reiser J, Coward RJ, Inward CD, et al. (2002) A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 13: 630-638.
55. Ortiz A, Lorz C, González-Cuadrado S, Garcia del Moral R, O'Valle F, et al. (1997) Cytokines and Fas regulate apoptosis in murine renal interstitial fibroblasts. J Am Soc Nephrol 8(12): 1845-54.